Yao Y - Search Results

1

KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

Lin F, Shen Z, Tang LN, Zheng SE, Sun YJ, Min DL, Yao Y. Lin F, et al. Among authors: yao y. Mol Med Rep. 2014 May;9(5):1613-7. doi: 10.3892/mmr.2014.2027. Epub 2014 Mar 7. Mol Med Rep. 2014. PMID: 24604387 Free PMC article.

2

[Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers].

Sun YJ, Zhao H, Guo YW, Lin F, Cai X, Tang XC, Yao Y. Sun YJ, et al. Among authors: yao y. Zhonghua Zhong Liu Za Zhi. 2004 Dec;26(12):749-52. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15733397 Chinese.

3

[Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer].

Yao Y, Sun YJ, Zhao H, Guo YW, Lin F, Cai X, Tang XC. Yao Y, et al. Ai Zheng. 2006 Aug;25(8):1035-8. Ai Zheng. 2006. PMID: 16965689 Chinese.

4

Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.

Yao Y, Sun YJ, Zhao H, Guo YW, Lin F, Cai X, Tang XC, Tang LN, Zhang W. Yao Y, et al. Chin Med J (Engl). 2006 Nov 5;119(21):1829-33. Chin Med J (Engl). 2006. PMID: 17097039 No abstract available.

5

Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer.

Yao Y, Zhao H, Sun Y, Lin F, Tang L, Chen P. Yao Y, et al. Tohoku J Exp Med. 2008 Jul;215(3):267-78. doi: 10.1620/tjem.215.267. Tohoku J Exp Med. 2008. PMID: 18648187 Free article.

6

The expression of CRM1 is associated with prognosis in human osteosarcoma.

Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Chen P, Sun YJ, Tang LN, Zheng SE. Yao Y, et al. Oncol Rep. 2009 Jan;21(1):229-35. Oncol Rep. 2009. PMID: 19082467

7

Down-regulation of ribosomal protein L7A in human osteosarcoma.

Zheng SE, Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Sun YJ, Tang LN. Zheng SE, et al. Among authors: yao y. J Cancer Res Clin Oncol. 2009 Aug;135(8):1025-31. doi: 10.1007/s00432-008-0538-4. Epub 2009 Jan 6. J Cancer Res Clin Oncol. 2009. PMID: 19125294

8

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.

Lin F, Zheng SE, Shen Z, Tang LN, Chen P, Sun YJ, Zhao H, Yao Y. Lin F, et al. Among authors: yao y. Med Oncol. 2011 Jun;28(2):649-53. doi: 10.1007/s12032-010-9493-4. Epub 2010 Mar 27. Med Oncol. 2011. PMID: 20349215

9

Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis.

Zhao H, Yao Y, Wang Z, Lin F, Sun Y, Chen P. Zhao H, et al. Among authors: yao y. J Chemother. 2010 Apr;22(2):119-24. doi: 10.1179/joc.2010.22.2.119. J Chemother. 2010. PMID: 20435572

10

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer.

Qi WX, Shen Z, Yao Y. Qi WX, et al. Among authors: yao y. Cancer Chemother Pharmacol. 2012 Jan;69(1):99-106. doi: 10.1007/s00280-011-1678-9. Epub 2011 May 24. Cancer Chemother Pharmacol. 2012. PMID: 21607554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,656 results

Search Page

Filters